Chung‐Chi Hsu

656 total citations
12 papers, 379 citations indexed

About

Chung‐Chi Hsu is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Chung‐Chi Hsu has authored 12 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Chung‐Chi Hsu's work include Cancer Cells and Metastasis (6 papers), Epigenetics and DNA Methylation (5 papers) and Microtubule and mitosis dynamics (3 papers). Chung‐Chi Hsu is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Epigenetics and DNA Methylation (5 papers) and Microtubule and mitosis dynamics (3 papers). Chung‐Chi Hsu collaborates with scholars based in Taiwan, United States and Israel. Chung‐Chi Hsu's co-authors include Kelvin K. Tsai, Wen‐Ying Liao, Tze‐Sian Chan, Wei‐Yu Chen, Chi–Rong Li, Yan‐Shen Shan, Chia-Jui Yen, Chih‐Pin Chuu, Shenq‐Shyang Huang and Valerie M. Weaver and has published in prestigious journals such as The Journal of Experimental Medicine, Cancer Research and Oncogene.

In The Last Decade

Chung‐Chi Hsu

12 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chung‐Chi Hsu Taiwan 8 240 187 115 79 65 12 379
Shivee Gilja United States 3 175 0.7× 207 1.1× 117 1.0× 47 0.6× 37 0.6× 5 359
Jingde Chen China 10 279 1.2× 90 0.5× 128 1.1× 78 1.0× 44 0.7× 21 370
Daniela I. Paiva‐Oliveira Portugal 6 197 0.8× 150 0.8× 101 0.9× 77 1.0× 51 0.8× 7 328
Maren Pein Germany 6 166 0.7× 211 1.1× 101 0.9× 51 0.6× 121 1.9× 8 384
Robiya Joseph United States 8 244 1.0× 133 0.7× 134 1.2× 67 0.8× 39 0.6× 18 362
Christin Ungewiss United States 7 305 1.3× 175 0.9× 215 1.9× 49 0.6× 56 0.9× 8 476
Longwen Xu China 10 185 0.8× 172 0.9× 94 0.8× 61 0.8× 81 1.2× 24 361
Justin Wang United States 9 206 0.9× 144 0.8× 87 0.8× 45 0.6× 122 1.9× 12 430
Anke Van den broeck Belgium 6 233 1.0× 285 1.5× 128 1.1× 46 0.6× 53 0.8× 9 433
Ryan Lupo United States 6 248 1.0× 166 0.9× 111 1.0× 35 0.4× 110 1.7× 7 399

Countries citing papers authored by Chung‐Chi Hsu

Since Specialization
Citations

This map shows the geographic impact of Chung‐Chi Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Chi Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Chi Hsu more than expected).

Fields of papers citing papers by Chung‐Chi Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Chi Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Chi Hsu. The network helps show where Chung‐Chi Hsu may publish in the future.

Co-authorship network of co-authors of Chung‐Chi Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Chung‐Chi Hsu. A scholar is included among the top collaborators of Chung‐Chi Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung‐Chi Hsu. Chung‐Chi Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chan, Tze‐Sian, Chung‐Chi Hsu, Pei‐Ming Yang, et al.. (2024). ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells. Molecular Oncology. 18(3). 562–579. 2 indexed citations
2.
Tsai, Kelvin K., et al.. (2023). Oncogenic ASPM Is a Regulatory Hub of Developmental and Stemness Signaling in Cancers. Cancer Research. 83(18). 2993–3000. 10 indexed citations
3.
Hsu, Chung‐Chi, Hung‐Wen Tsai, Wen‐Ying Liao, et al.. (2023). ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell Lung Cancer Stemness and Progression. Cancer Research. 83(6). 830–844. 24 indexed citations
4.
Tsai, Kelvin K., Shenq‐Shyang Huang, Jason J. Northey, et al.. (2022). Screening of organoids derived from patients with breast cancer implicates the repressor NCOR2 in cytotoxic stress response and antitumor immunity. Nature Cancer. 3(6). 734–752. 28 indexed citations
5.
Hsu, Chung‐Chi, Wen‐Ying Liao, Kwang‐Yu Chang, et al.. (2021). Correction to: A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer. Gastric Cancer. 24(3). 640–641. 2 indexed citations
6.
Hsu, Chung‐Chi, Wen‐Ying Liao, Kwang‐Yu Chang, et al.. (2021). A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer. Gastric Cancer. 24(3). 624–639. 15 indexed citations
7.
Liao, Wen‐Ying, Chung‐Chi Hsu, Tze‐Sian Chan, et al.. (2020). Dishevelled 1-Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma. Stem Cell Reports. 14(3). 462–477. 25 indexed citations
8.
Hsu, Chung‐Chi, Wen‐Ying Liao, Tze‐Sian Chan, et al.. (2019). The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis. The Journal of Pathology. 249(4). 498–508. 39 indexed citations
9.
Hsu, Chung‐Chi, Tze‐Sian Chan, Wen‐Ying Liao, et al.. (2018). ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling. Oncogene. 38(8). 1340–1353. 95 indexed citations
10.
Tsai, Kelvin K., et al.. (2017). Abstract 4763: Metronomic chemotherapy prevents therapy-induced stromal activation and induction of cancer stem cells. Cancer Research. 77(13_Supplement). 4763–4763. 3 indexed citations
11.
Chan, Tze‐Sian, Chung‐Chi Hsu, Wen‐Ying Liao, et al.. (2016). Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells. The Journal of Experimental Medicine. 213(13). 2967–2988. 132 indexed citations
12.
Hsu, Chung‐Chi, et al.. (2002). The autoantibody expression against different source of oxidized low density lipoprotein in patients with acute myocardial infarction. Thrombosis Research. 107(3-4). 175–179. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026